Literature DB >> 12906836

Macrophage turnover, division and activation within developing, peak and "healed" tuberculous lesions produced in rabbits by BCG.

Arthur M Dannenberg1.   

Abstract

This review is a synthesis and analysis of our nine experimental pathology papers on macrophage kinetics in dermal tuberculous lesions produced in rabbits by BCG. It is presented at this time to summarize the macrophage kinetics in both active and essentially healed tuberculous lesions and to suggest that the bacilli frequently multiply and are destroyed in the viable granulation tissue of many small arrested tuberculous lesions. The turnover of mononuclear cells (MN)-which were mostly macrophages with some medium and large lymphocytes-was most rapid in BCG lesions at 2-3 weeks (when tuberculin sensitivity and acquired cellular resistance were at their peaks). At this time, more macrophages entered, more died or left, more remained at the site, and more became activated than before or afterwards. Before this time, the host had no delayed-type hypersensitivity (DTH) and cell-mediated immunity (CMI), so that no antigen-specific enhancement of the inflammatory response occurred. After this time, the bacilli and their antigenic products had decreased, so that the stimuli for cell infiltration and activation were reduced. In "healed" lesions, the MN turnover still occurred, but was decreased. The continuous entry of live non-activated macrophages into the viable parts of tuberculous lesions provides fresh intracellular sites where tubercle bacilli may multiply before they are again inhibited by the DTH and CMI of the host. In tuberculosis, bacillary dormancy of long duration may only be present in caseous necrotic tissue where no live host cells exist.

Entities:  

Mesh:

Year:  2003        PMID: 12906836     DOI: 10.1016/s1472-9792(03)00048-9

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  13 in total

1.  Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism.

Authors:  Kristin N Adams; Kevin Takaki; Lynn E Connolly; Heather Wiedenhoft; Kathryn Winglee; Olivier Humbert; Paul H Edelstein; Christine L Cosma; Lalita Ramakrishnan
Journal:  Cell       Date:  2011-03-03       Impact factor: 41.582

Review 2.  Immunity and Immunopathology in the Tuberculous Granuloma.

Authors:  Antonio J Pagán; Lalita Ramakrishnan
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-06       Impact factor: 6.915

Review 3.  Perspectives on clinical and preclinical testing of new tuberculosis vaccines.

Authors:  Arthur M Dannenberg
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 4.  Revisiting the role of the granuloma in tuberculosis.

Authors:  Lalita Ramakrishnan
Journal:  Nat Rev Immunol       Date:  2012-04-20       Impact factor: 53.106

5.  pH-Responsive Isoniazid-Loaded Nanoparticles Markedly Improve Tuberculosis Treatment in Mice.

Authors:  Angela A Hwang; Bai-Yu Lee; Daniel L Clemens; Barbara Jane Dillon; Jeffrey I Zink; Marcus A Horwitz
Journal:  Small       Date:  2015-07-20       Impact factor: 13.281

6.  Hematopoietic Stem Cell Requirement for Macrophage Regeneration Is Tissue Specific.

Authors:  Devon J Eddins; Astrid Kosters; Jeffrey Waters; Jasmine Sosa; Megan Phillips; Koshika Yadava; Leonore A Herzenberg; Hedwich F Kuipers; Eliver Eid Bou Ghosn
Journal:  J Immunol       Date:  2021-11-22       Impact factor: 5.426

7.  Antimicrobial efflux pumps and Mycobacterium tuberculosis drug tolerance: evolutionary considerations.

Authors:  John D Szumowski; Kristin N Adams; Paul H Edelstein; Lalita Ramakrishnan
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

8.  In vivo expression of innate immunity markers in patients with Mycobacterium tuberculosis infection.

Authors:  Pantelis Constantoulakis; Eftihia Filiou; Nikoletta Rovina; George Chras; Aggeliki Hamhougia; Simona Karabela; Adamandia Sotiriou; Charis Roussos; Nikolaos Poulakis
Journal:  BMC Infect Dis       Date:  2010-08-18       Impact factor: 3.090

9.  The role of the granuloma in expansion and dissemination of early tuberculous infection.

Authors:  J Muse Davis; Lalita Ramakrishnan
Journal:  Cell       Date:  2009-01-09       Impact factor: 41.582

10.  Myeloid Growth Factors Promote Resistance to Mycobacterial Infection by Curtailing Granuloma Necrosis through Macrophage Replenishment.

Authors:  Antonio J Pagán; Chao-Tsung Yang; James Cameron; Laura E Swaim; Felix Ellett; Graham J Lieschke; Lalita Ramakrishnan
Journal:  Cell Host Microbe       Date:  2015-07-08       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.